A comparative investigation of the restorative effects of roxithromycin on neutrophil activities

International Journal of Immunopharmacology

Volumn 20, Issue 11, 1998, Pages 615-624

  Noma, Takeshi ^a   Hayashi, Masaharu ^b   Yoshizawa, Izumi ^b   Aoki, Kuniteru ^b   Shikishima, Yasufumi ^a   Kawano, Yutaka ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Neutrophil; Neutrophil bactericidal activity; Phagocytosis; Roxithromycin

Indexed keywords

AZTREONAM; CEFACLOR; OFLOXACIN; ROXITHROMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISABLED PERSON; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MENTAL DEFICIENCY; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZTREONAM; BLOOD BACTERICIDAL ACTIVITY; CEFACLOR; CEPHALOSPORINS; CHILD; DISABLED PERSONS; DRUG INTERACTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; MACROPHAGE-1 ANTIGEN; MALE; MONOBACTAMS; NEUTROPHILS; OFLOXACIN; PHAGOCYTOSIS; ROXITHROMYCIN;

EID: 0032477265     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00010-1     Document Type: Article

References (20)

1. Asano T., Yokota T. Chemotherapy (Tokyo). 34:1986;973.
2. Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C., Thomas M. J. Immunol. 130:1983;1910.
3. Bishop M. B., Baltch A. L., Hill L. A., Smith R. P., Lutz F., Pollack M. J. Med. Microbiol. 24:1987;315.
4. Bonnet M., van der Auwera P. Antimicrob. Agents Chemother. 37:1993;1015.
5. Broek P. J. Rev. Infect. Dis. 11:1989;213.
6. Dunn P. A., Tyrer H. W. J. Lab. Clin. Med. 98:1981;374.
7. Gemmell C. G. Antimicrob. Chemother. 31:1993;23.
8. Hand W. E., King-Thompson N., Holman J. W. Antimicrobial Agents Chemother. 31:1987;1553.
9. Hasui M., Hirabayashi Y., Kobayashi Y. J. Immunol. 117:1989;53.
10. Jakubowski A. A., Souza L., Kelly F., Fain K., Budman D., Clarkson B., Bonilla M. A., Moore M. A. S., Gabrilove J. New Engl. J. Med. 320:1989;38.
11. Kawano Y., Noma T., Yoshizawa I., Maruki K., Yata J. Eur. J. Pediatr. 153:1994;884.
12. Kubo S., Matsumoto T., Takahashi K. Chemotherapy (Switzerland). 40:1993;333.
13. Labro M. T., El Benna J., Abdelghaffer H. Antimicrob. Chemother. 31:1993;51.
14. Ogawa M. Chemotherapy (Tokyo). 34:1986;1.
15. Prieto J. P., Minguez F., Ortega P., Corrales I., Ledesma V. Bri. J. Clin. Prac. 42:1988;38.
16. Sorensen R. U., Klinger J. D. Antibiot. Chemother. 39:1987;113.
17. Tamagawa K., Hasegawa H., Hayashi N., Ishihara K. No to Hattatsu (Tokyo). 7:1975;46.
18. Weening R. S., Bredius R. G. M., Vomberg P. P., van der Schoot C. E., Hoogerwerf M., Roos D. Eur. J. Pediatr. 151:1992;103.
19. Wheeler, J. G., Abramson, J. S. (1993). Microbial and pharmacological induction of neutrophil dysfunction, In: Abramson, J. S. and Wheeler, J. G. (Eds.), The Neutrophil, Oxford University Press: New York, 139.
20. Yokota T., Bhattacharyya I. Bri. J. Clin. Prac. 42:1988;40.